SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002227
Filing Date
2022-01-26
Accepted
2022-01-26 06:05:26
Documents
13
Period of Report
2022-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 36815
2 ex99-1.htm EX-99.1 11452
  Complete submission text file 0001493152-22-002227.txt   226585

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytr-20220125.xsd EX-101.SCH 3024
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytr-20220125_lab.xml EX-101.LAB 35156
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytr-20220125_pre.xml EX-101.PRE 23023
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3703
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 22555610
SIC: 2836 Biological Products, (No Diagnostic Substances)